HCV infection of the transplanted liver: Changing CD81 and HVR1 variants immediately after liver transplantation

American Journal of Transplantation

Volumn 5, Issue 10, 2005, Pages 2504-2513

  Hughes Jr , Michael G ^a   Chong, Tae W ^a   Smith, Robert L ^a   Evans, Heather L ^a   Iezzoni, Julia C ^a   Sawyer, Robert G ^a   Rudy, Christine K ^a   Pruett, Timothy L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Disease recurrence; HCV; Liver transplantation; Quasispecies

Indexed keywords

CD81 ANTIGEN; CELL SURFACE RECEPTOR; VIRUS ENVELOPE PROTEIN; HEPATITIS C ANTIBODY; HVR1 PROTEIN, HEPATITIS C VIRUS; LEUKOCYTE ANTIGEN; RNA; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; BLOOD SAMPLING; CASE REPORT; CLONE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC VARIABILITY; GRAFT INFECTION; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; REPERFUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CELL INTERACTION; ALLOTRANSPLANTATION; AMINO ACID SEQUENCE; BIOPSY; BIOSYNTHESIS; CELL MEMBRANE; CHEMISTRY; DNA SEQUENCE; HEPATITIS C VIRUS; LIVER; METABOLISM; METHODOLOGY; MOLECULAR CLONING; MOLECULAR GENETICS; PATHOLOGY; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; SEQUENCE HOMOLOGY; TIME; VIROLOGY;

AMINO ACID SEQUENCE; ANTIGENS, CD; BIOPSY; CELL MEMBRANE; CLONING, MOLECULAR; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER TRANSPLANTATION; MOLECULAR SEQUENCE DATA; POSTOPERATIVE COMPLICATIONS; RECURRENCE; REPERFUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; VARIATION (GENETICS); VIRAL PROTEINS;

EID: 33644691090     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01060.x     Document Type: Article

References (48)

1. Wright TL Pereira B. Liver transplantation for chronic viral hepatitis. Liver Transpl Surg 1995 1 : 30 42.
2. Gretch DR Bacchi CE Corey L et al. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology 1995 22 : 1 9.
3. Ballardini G De Raffele E Groff P et al. Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver. Liver Transpl 2002 8 : 10 20.
4. Vargas V Krawczynski K Castells L et al. Recurrent hepatitis C virus infection after liver transplantation: immunohistochemical assessment of the viral antigen. Liver Transpl Surg 1998 4 : 320 327.
5. Garcia-Retortillo M Forns X Feliu A et al. Hepatitis C virus kinetics during and immediately after liver transplantation. Hepatology 2002 35 : 680 687.
6. Weiner AJ Geysen HM Christopherson C et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992 89 : 3468 3472.
7. Weiner AJ Brauer MJ Rosenblatt J et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991 180 : 842 848.
8. Lin HJ Seeff LB Barbosa L Hollinger FB. Occurrence of identical hypervariable region 1 sequences of hepatitis C virus in transfusion recipients and their respective blood donors: divergence over time. Hepatology 2001 34 : 424 429.
9. Higashi Y Kakumu S Yoshioka K et al. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 1993 197 : 659 668.
10. Ray SC Mao Q Lanford RE et al. Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees. J Virol 2000 74 : 3058 3066.
11. Martell M Esteban JI Quer J et al. Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. J Virol 1994 68 : 3425 3436.
12. Rumin S Berthillon P Tanaka E et al. Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro. J Gen Virol 1999 80 : 3007 3018.
13. Hughes MG Jr.. Rudy CK Chong TW et al. E2 quasispecies specificity of hepatitis C virus association with allografts immediately after liver transplantation. Liver Transpl 2004 10 : 208 216.
14. Pileri P Uematsu Y Campagnoli S et al. Binding of hepatitis C virus to CD81. Science 1998 282 : 938 941.
15. Flint M Maidens C Loomis-Price LD et al. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J Virol 1999 73 : 6235 6244.
16. Allander T Forns X Emerson SU Purcell RH Bukh J. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins. Virology 2000 277 : 358 367.
17. Bartosch B Vitelli A Granier C et al. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem 2003 278 : 41624 41630.
18. Cormier EG Tsamis F Kajumo F Durso RJ Gardner JP Dragic T. CD81 is an entry coreceptor for hepatitis C virus. Proc Natl Acad Sci USA 2004 101 : 7270 7274.
19. Wunschmann S Medh JD Klinzmann D Schmidt WN Stapleton JT. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J Virol 2000 74 : 10055 10062.
20. Agnello V Abel G Elfahal M Knight GB Zhang QX. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA 1999 96 : 12766 12771.
21. Lozach PY Amara A Bartosch B et al. C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. J Biol Chem 2004 279 : 32035 32045.
22. Gardner JP Durso RJ Arrigale RR et al. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc Natl Acad Sci USA 2003 100 : 4498 4503.
23. Pohlmann S Zhang J Baribaud F et al. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 2003 77 : 4070 4080.
24. Takikawa S Ishii K Aizaki H et al. Cell fusion activity of hepatitis C virus envelope proteins. J Virol 2000 74 : 5066 5074.
25. Penin F Combet C Germanidis G Frainais PO Deleage G Pawlotsky JM. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J Virol 2001 75 : 5703 5710.
26. Germi R Crance JM Garin D et al. Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption. J Med Virol 2002 68 : 206 215.
27. Basu A Beyene A Meyer K Ray R. The hypervariable region 1 of the e2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system. J Virol 2004 78 : 4478 4486.
28. Barth H Schafer C Adah MI et al. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparin sulfate. J Biol Chem 2003 278 : 41003 41012.
29. Owsianka A Clayton RF Loomis-Price LD McKeating JA Patel AH. Functional analysis of hepatitis C virus E2 glycoproteins and virus- like particles reveals structural dissimilarities between different forms of E2. J Gen Virol 2001 82 : 1877 1883.
30. Loriot MA Bronowicki JP Lagorce D et al. Permissiveness of human biliary epithelial cells to infection by hepatitis C virus. Hepatology 1999 29 : 1587 1595.
31. Farci P Shimoda A Wong D et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci USA 1996 93 : 15394 15399.
32. Farci P Alter HJ Wong DC et al. Prevention of hepatitis C virus infection in chimpanzees after antibody- mediated in vitro neutralization. Proc Natl Acad Sci USA 1994 91 : 7792 7796.
33. Cabot B Martell M Esteban JI et al. Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver. J Virol 2000 74 : 805 811.
34. Pelletier SJ Raymond DP Crabtree TD et al. Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate. Hepatology 2000 32 : 418 426.
35. Henikoff S Henikoff J. Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci USA 1992 89 : 10915 10919.
36. Wolinsky SM Korber BT Neumann AU et al. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 1996 272 : 537 542.
37. Pawlotsky JM Germanidis G Frainais PO et al. Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy. J Virol 1999 73 : 6490 6499.
38. Sullivan DG Wilson JJ Carithers RL Jr.. Perkins JD Gretch DR. Multigene tracking of hepatitis C virus quasispecies after liver transplantation: correlation of genetic diversification in the envelope region with asymptomatic or mild disease patterns. J Virol 1998 72 : 10036 10043.
39. Yun Z Barkholt L Sonnerborg A. Dynamic analysis of hepatitis C virus polymorphism in patients with orthotopic liver transplantation. Transplantation 1997 64 : 170 172.
40. Gretch DR Polyak SJ Wilson JJ Carithers RL Jr.. Perkins JD Corey L. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol 1996 70 : 7622 7631.
41. Feliu A Gay E Garcia-Retortillo M Saiz JC Forns X. Evolution of hepatitis C virus quasispecies immediately following liver transplantation. Liver Transpl 2004 10 : 1131 1139.
42. Kato N Ikeda M Sugiyama K Mizutani T Tanaka T Shimotohno K. Hepatitis C virus population dynamics in human lymphocytes and hepatocytes infected in vitro. J Gen Virol 1998 79 ( Pt 8 1859 1869.
43. Forns X Thimme R Govindarajan S et al. Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. Proc Natl Acad Sci USA 2000 97 : 13318 13323.
44. Zibert A Schreier E Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 1995 208 : 653 661.
45. Zhou YH Shimizu YK Esumi M. Monoclonal antibodies to the hypervariable region 1 of hepatitis C virus capture virus and inhibit virus adsorption to susceptible cells in vitro. Virology 2000 269 : 276 283.
46. Shimizu YK Igarashi H Kiyohara T et al. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 1996 223 : 409 412.
47. Rosa D Campagnoli S Moretto C et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci USA 1996 93 : 1759 1763.
48. Scarselli E Ansuini H Cerino R et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. Embo J 2002 21 : 5017 5025.